Table 2 Inclusion and exclusion criteria

Have SLI due to atherosclerotic FP, ± IP, PAD

Have an anticipated life expectancy <6 months

Be judged by the responsible clinicians (consultant VS, IR) working as part of a MDT to: Require early FP, ± IP, endovascular revascularisation in addition to BMT, foot and wound care

Be, in the opinion of the clinician, unable to provide informed consent

Have or will have adequate ‘inflow’ to support all trial revascularisation strategies

Be a non-English speaker where local translation facilities are insufficient to guarantee informed consent

Judged suitable for all trial revascularisation strategies following diagnostic imaging and a documented MDT discussion

Be judged unsuitable for the endovascular revascularisation strategies by a vascular MDT

Able to complete QoL and resource use booklet

Previous intervention (BET or bypass) to the target vessel within the past 12 months